about
Prevalence and characteristics of mild cognitive impairment in the general population. Data from an Italian population-based study: The Faenza Project.Prevalence of dementia and factors associated with dementia in rural Bangladesh: data from a cross-sectional, population-based study.Comparison of anthropometric measurements in children to predict metabolic syndrome in adolescence: analysis of prospective cohort data.Late-life body mass index and dementia incidence: nine-year follow-up data from the Kungsholmen Project.Detection of Alzheimer's disease and dementia in the preclinical phase: population based cohort study.Predictors of progression from mild cognitive impairment to Alzheimer disease.Mild cognitive impairment: continuing controversies.Predictors of progression of cognitive decline in Alzheimer's disease: the role of vascular and sociodemographic factors.Time to face the challenge of multimorbidity. A European perspective from the joint action on chronic diseases and promoting healthy ageing across the life cycle (JA-CHRODIS).Inverse occurrence of cancer and Alzheimer disease: a population-based incidence study.Glaucoma Surgery Outcome in Rwanda.Adherence to Selective Serotonin and Serotonin-Norepinephrine Reuptake Inhibitor Prescriptions Affects Overall Medication Adherence in Older Persons: Evidence From the Italian Nationwide OsMed Health-DB Database.The changing importance of key factors associated with anaemia in 6- to 59-month-old children in a sub-Saharan African setting where malaria is on the decline: analysis of the Rwanda Demographic and Health Survey 2010.Strategies to Improve Medication Adherence in Older Persons: Consensus Statement from the Senior Italia Federanziani Advisory Board.Mild cognitive impairment in the general population: occurrence and progression to Alzheimer disease.Early symptoms and signs of cognitive deficits might not always be detectable in persons who develop Alzheimer's disease.Heterogeneity in risk factors for cognitive impairment, no dementia: population-based longitudinal study from the Kungsholmen Project.Advanced Age and Medication Prescription: More Years, Less Medications? A Nationwide Report From the Italian Medicines Agency.Assessing the Impact of Atopic Dermatitis on the Patients' Parents with the Visual Instrument 'Caregiver-PRISM'.Differential evolution of cognitive impairment in nondemented older persons: results from the Kungsholmen Project.Frailty and Drug Use.Prevalence of depressive symptoms and suicidal thoughts among elderly persons in rural Bangladesh.Are guidelines needed for the diagnosis and management of incipient Alzheimer's disease and mild cognitive impairment?High plasma levels of vitamin E forms and reduced Alzheimer's disease risk in advanced age.The combined effect of age, education, and stroke on dementia and cognitive impairment no dementia in the elderly.Color discrimination performance in patients with Alzheimer's disease.Cognitive impairment after age 60: clinical and social correlates in the Faenza Project.Neuropsychiatric symptoms and syndromes in institutionalized elderly people without dementia.The role of persistent and incident major depression on rate of cognitive deterioration in newly diagnosed Alzheimer's disease patients.News from epidemiological studies on Alzheimer's and Parkinson's disease: a personal perspective.Anaemia increases the risk of dementia in cognitively intact elderly.The Relationship between Cognitive Reserve and Math Abilities.Multimorbidity care model: Recommendations from the consensus meeting of the Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (JA-CHRODIS).Depression, vascular factors, and risk of dementia in primary care: a retrospective cohort study.Clinical Criteria for Tracheostomy Decannulation in Subjects with Acquired Brain Injury.Occurrence of neuropsychiatric symptoms and psychiatric disorders in mild Alzheimer's disease and mild cognitive impairment subtypes.Alexithymia is a non-motor symptom of Parkinson disease.Neuropsychiatric symptoms and syndromes in a large cohort of newly diagnosed, untreated patients with Alzheimer disease.Associations Between Functional Biological Age and Cognition Among Older Adults in Rural Bangladesh: Comparisons With Chronological Age.Predicting disease progression in Alzheimer's disease: the role of neuropsychiatric syndromes on functional and cognitive decline.
P50
Q30573692-39A7DB9C-94C9-4C24-A26F-84CD72086A09Q30836927-16559403-9D21-4FF1-8A03-C1FFB5431569Q30930873-6B4BBAC2-C7DA-4D6E-A188-C5A3D958C7EEQ33306599-63DE6FE3-3828-43B4-B259-1710324DE6FFQ34463982-A51F4706-A721-4CDC-A6B2-703A6BCA6FCDQ34579287-A3653646-FD79-4171-A677-3B8002383B2CQ36728579-CA87EFC6-85C5-4E81-AA54-3B9360775C5AQ37292162-7FB0F18A-F7B0-4B2D-95D0-5C3052F176AEQ38386969-28B616DE-1A6C-44E2-9EA7-AF47716E45CEQ38425488-34C499B6-CAF1-4F30-84B7-FA5040BCDB1EQ38967092-CC4C20A0-FC2B-43A1-A865-430E6C76C9D6Q39021867-EE609882-7346-467C-A920-D9FC972D3FE5Q39306986-7AF3EF31-8014-4EA1-B899-45BD8BD82824Q39574426-DDD457C4-C4A0-4785-983F-CF90E8BD1FC8Q40075628-F04BAAC7-FB13-48CE-8797-BAEC00F2E277Q40126067-94ABFBF6-78EF-40E9-A2E8-7C1A45162665Q40256600-5B807769-A17B-4643-A42F-727C5BE0FC32Q40461267-8B73071A-BA8D-4707-9785-BE11D849060BQ40607650-9CE703AF-66DC-4138-A904-5290306185E3Q40656856-04A5EFC2-CC8F-4807-8223-41666D27E8C4Q40736256-44169C57-7494-4F75-A2F0-1811872FF0E6Q41506673-1684FE90-319E-4F65-B576-BD46B27209D4Q41982613-D3FF900E-05E2-4FB0-8A63-9F8FAC29D244Q43088178-664A0728-F1C2-41D5-9375-104DC8DC1E40Q43922373-26C5411C-0C11-4E4A-A0F8-F1E6B39C963EQ43925648-FCF14BDA-19CB-4616-8EB2-A87558BA7EC0Q44370769-79060872-7922-4052-9144-2E27DF7BB5F0Q44879701-ACDB9F4F-11B1-4C05-A7CF-3458730517C1Q45131184-785A2714-D356-4C20-A86F-5271CF9842DFQ46158414-556A9A79-13DE-4C9B-9FB9-72D589FE00B1Q47274119-CA95BED1-1587-432E-B2B9-029E1BABBE17Q47557971-3BAA6724-45CF-47C2-8365-411A810FE0D3Q47670424-C03A3EFA-C5A5-4E56-B1A1-E96FB4EAC7FCQ48084888-2963BB2A-DDE8-4B1B-A982-88E3AC34ACE3Q48200610-F1C11823-E82F-45D9-B366-73D01DDD1E72Q48248458-34C7B142-F12F-4F29-85CD-19796C1C4436Q48745976-0DF7D708-6C2A-4AAC-84FE-3AA367DDF20AQ49060581-7A42A1D5-4004-46EF-B1B4-79BDB32EF6CEQ50019118-82B78227-CD49-4B4C-8E4F-A5BCE9683269Q50653744-8E5B10FD-1EE5-4166-B641-B5035C171B1C
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Katie Palmer
@ast
Katie Palmer
@en
Katie Palmer
@es
Katie Palmer
@nl
Katie Palmer
@sl
كاتي بالمر
@ar
type
label
Katie Palmer
@ast
Katie Palmer
@en
Katie Palmer
@es
Katie Palmer
@nl
Katie Palmer
@sl
كاتي بالمر
@ar
prefLabel
Katie Palmer
@ast
Katie Palmer
@en
Katie Palmer
@es
Katie Palmer
@nl
Katie Palmer
@sl
كاتي بالمر
@ar
P214
P244
P1053
A-1430-2016
P106
P21
P213
0000 0000 4589 3448
P214
P244
no2003052484
P31
P3829
P496
0000-0001-8783-016X
P734
P735
P7859
lccn-no2003052484